Video Experimental Relacionado
Updated: Feb 28, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
3.6K
PASADO, PRESENTE y FUTURO DE LA NEFRITIS LÚPICA
Claudio Ponticelli1, Gabriella Moroni2,3
1Independent Researcher, Via Ampere 126, Milan, Italy.
Expert review of clinical immunology
|February 25, 2026
Resumen
Esta revisión rastrea la historia de la clasificación y el tratamiento de la nefritis lúpica (NL), destacando las estrategias pasadas, presentes y futuras. Las direcciones futuras enfatizan la medicina personalizada y la IA para mejorar los resultados de los pacientes.
Área de la Ciencia:
- Nefrología
- Inmunología
- Patología
Sus antecedentes:
- El manejo de la nefritis lúpica (NL) ha evolucionado significativamente, sin embargo, muchos pacientes enfrentan una mala calidad de vida y complicaciones renales.
- Comprender la progresión histórica de la clasificación y el tratamiento de la NL es crucial para los avances futuros.
Objetivo del estudio:
- Delinear la evolución de las clasificaciones histológicas y las estrategias de manejo de la nefritis lúpica (NL).
- Revisar las direcciones pasadas (1950-2000), presentes (2001-presente) y futuras en el tratamiento y pronóstico de la NL.
Principales métodos:
- Búsqueda bibliográfica exhaustiva en las bases de datos PubMed, Medline y Embase.
- Revisión histórica de las clasificaciones histológicas de la nefritis lúpica (NL) y los enfoques farmacológicos.
- Análisis del manejo actual, pronóstico y estrategias terapéuticas futuras.
Principales resultados:
- Se han logrado avances significativos en el diagnóstico y manejo de la NL desde 2001.
- Las décadas pasadas se centraron en prevenir la progresión de la enfermedad renal y los brotes a través de medios farmacológicos.
- Las estrategias futuras implican medicina personalizada, IA y biomarcadores novedosos para mejorar la supervivencia renal.
Conclusiones:
- La trayectoria del manejo de la nefritis lúpica (NL) muestra una mejora continua, sin embargo, persisten los desafíos.
- La investigación futura y la práctica clínica probablemente integrarán la medicina personalizada, la IA y las terapias innovadoras.
- La comprensión y aplicación mejoradas de estos avances prometen una mejor supervivencia renal a largo plazo y calidad de vida para los pacientes con NL.
Videos de Conceptos Relacionados
01:26Nephrotic Syndrome II : Assessment and Medical Management
279
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
279
01:24Nephrotic Syndrome I : Introduction
748
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
748
01:24Nephrotic Syndrome III : Nursing Management
398
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
398
01:29Acute Kidney Injury III: Clinical Manifestations
1.1K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K
01:24Chronic Kidney Disease II: Clinical Manifestations
795
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
795
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
532
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
532